Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients

Overview of attention for article published in Breast Cancer Research and Treatment, August 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 3,847 followers.

RT @pmg_flinders: Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ adva…

13 Jan 2020

Reply Repost Favourite

Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients #cancer #breastcancer #precisionmedicine @Flinders @cancerFCIC @FlindersLib https://t.co/at2h6udbCs

13 Jan 2020

Reply Repost Favourite

Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients. - PubMed - NCBI https://t.co/xMBHEHmdMj

18 Sep 2019

Reply Repost Favourite

RT @filimasini: Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanc…

18 Aug 2019

Reply Repost Favourite

Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients. - PubMed - NCBI https://t.co/L8DHIUhWUS

18 Aug 2019

Reply Repost Favourite